New Drug Offers Relief for Treatment-Resistant Epilepsy
NYU Langone study shows that new drug XEN1101 reduces seizure frequency and sometimes prevents them altogether in people with focal epilepsy.
New Drug Slows Progression of Advanced Breast Cancer
NYU Langone breast cancer expert Dr. Sylvia Adams discusses a new drug that slows the progression of advanced breast cancer.
New Eye Tracker Detects Concussion
Research conducted on patients with head trauma who visited emergency department shows eye tracking may detect concussion severity.
new-faculty-appointments.pdf
School of Medicine Announcement of Appointments, May 2025 – June 2025 Abdullah Aftab Clinical Assistant ...
New Father Gets a Heart, Lungs & Kidney—Just in Time
NYU Langone Transplant Institute team completes the region’s first heart–lung–kidney transplant, giving a new father a chance to raise his toddler.
New Fuchs Dystrophy Treatment Combines Surgery & Therapeutic
An approach pioneered by NYU Langone’s Dr. Kathryn A. Colby combines surgery and a novel application of ROCK inhibitors to treat Fuchs dystrophy.
New Fund for Complex Reconstructive Plastic Surgery Care
NYU Langone creates new charity care fund for patients in need of complex reconstructive plastic surgery.
New Fungal Skin Infections Have Reached U.S.
NYU Langone experts document the first case of a sexually transmitted form of jock itch and ringworm infection in the United States.
New Global Cancer Research Initiative Launches
An NYU Langone, Technion joint research venture focuses on melanoma and mesothelioma in first projects with funding from the Perlmutters.
New Guidelines for Surgical Management of Thyroid Disease
NYU Langone’s Dr. Kepal N. Patel is the lead author of new guidelines establishing best practices for surgically managing adult thyroid disease.